|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07J 63/00 | (2006.01) |
| C07J 63/008 | (2013.01) | ||
| A61K 31/56 | (2006.01) | ||
| A61P 5/40 | (2006.01) |
| (11) | Patento numeris | 3921327 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20709101.8 |
| Europos patento paraiškos padavimo data | 2020-02-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-12-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-04-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2020/017077 |
| Data | 2020-02-06 |
| (87) | Numeris | WO 2020/163642 |
| Data | 2020-08-13 |
| (30) | Numeris | Data | Šalis |
| 201962802210 P | 2019-02-07 | US |
| (72) |
DRAGOLI, Dean , US
LUEHR, Gary , US
CHEN, Tao , US
LEWIS, Jason , US
LEADBETTER, Michael , US
|
| (73) |
Ardelyx, Inc. ,
34175 Ardenwood Blvd., Suite 200, Fremont, California 94555,
US
|
| (54) | GLYCYRRHETINIC ACID DERIVATIVES FOR USE IN TREATING HYPERKALEMIA |
| GLYCYRRHETINIC ACID DERIVATIVES FOR USE IN TREATING HYPERKALEMIA |